These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
558 related items for PubMed ID: 10783659
21. [Case of ANCA-associated glomerulonephritis detected at an early phase]. Hayamai N, Kashiwagi T, Iino Y, Kitamura H, Kurihara S. Nihon Jinzo Gakkai Shi; 2005; 47(5):536-9. PubMed ID: 16130409 [Abstract] [Full Text] [Related]
22. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976 [Abstract] [Full Text] [Related]
23. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Hasegawa M, Nishii C, Ohashi A, Tomita M, Nakai S, Murakami K, Nabeshima K, Fujita Y, Ishii J, Hiki Y, Sugiyama S. Nephron Clin Pract; 2009 Mar; 113(3):c222-33. PubMed ID: 19690440 [Abstract] [Full Text] [Related]
24. [A case of microscopic polyangitis accompanied by hearing loss as the initial sign of the disease]. Koseki Y, Suwa A, Nojima T, Ishiyama K, Nakajima A, Tanabe M, Yamada T, Goto M, Yasui T, Inada S. Ryumachi; 1997 Dec; 37(6):804-9. PubMed ID: 9492568 [Abstract] [Full Text] [Related]
28. Systemic granulomatous necrotizing vasculitis in a MPO-ANCA-positive patient. Kurata A, Nishimura Y, Yamato T, Arimura Y, Yamada A, Sakamoto A, Fujioka Y. Pathol Int; 2004 Aug; 54(8):636-40. PubMed ID: 15260856 [Abstract] [Full Text] [Related]
29. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies]. Namba T, Hatanaka M, Takahashi A, Takeji M, Takahara K, Uzu T, Yamauchi A. Nihon Jinzo Gakkai Shi; 2008 Aug; 50(1):64-8. PubMed ID: 18318246 [Abstract] [Full Text] [Related]
34. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA. Rheumatology (Oxford); 2006 Jun 15; 45(6):724-9. PubMed ID: 16399845 [Abstract] [Full Text] [Related]
38. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease. Panamonta O, Sumethkul V, Radinahmed P, Laopaiboon M, Kirdpon W. J Pediatr Endocrinol Metab; 2008 Jun 15; 21(6):539-43. PubMed ID: 18717240 [Abstract] [Full Text] [Related]
39. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney. Yu F, Chen M, Wang SX, Zou WZ, Zhao MH, Wang HY. Nephrology (Carlton); 2007 Feb 15; 12(1):74-80. PubMed ID: 17295665 [Abstract] [Full Text] [Related]
40. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis. Almroth G, Berlin G, Andersson B, Hahn-Zoric M. Scand J Urol Nephrol; 2009 Feb 15; 43(2):160-70. PubMed ID: 18979374 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]